Reading Time: 2 minutesDiscover how PEYMAN Consulting helped a leading European pharma firm transform its quality inspection strategy, reduce CAPEX by over €3M, and build a roadmap for AI-enabled, Annex 1-compliant operations. This strategic advisory project redefined how the client approached asset upgrades, digital investments, and operational risk — enabling smarter decisions and real-time visibility across manufacturing. If you’re dealing with legacy inspection systems, compliance gaps, or investment prioritisation challenges, this case study reveals how a structured digital roadmap can deliver measurable value. Read on for insights tailored to biopharma executives, quality leaders, and digital transformation teams.
Browsing CategoryTechnology Due Diligence & IntegrationGet expert insights on evaluating and integrating technology solutions in the health tech industry. Learn how to assess digital health innovations, ensure regulatory compliance, and drive seamless technology adoption.
Get expert insights on evaluating and integrating technology solutions in the health tech industry. Learn how to assess digital health innovations, ensure regulatory compliance, and drive seamless technology adoption.
Unlocking 20x Returns in Digital Health Through Strategic M&A
Reading Time: 3 minutesThe $1.8 trillion digital health market is set for massive disruption, with 73% of its value driven by M&A between healthcare enterprises and AI-native startups. Despite holding $560 billion in untapped real-world data assets, traditional healthcare companies struggle with data monetization. Strategic acquisitions—such as IQVIA’s $7 billion spree—show that leveraging RWD can unlock 10-20x investment returns. This article explores how structured M&A strategies can transform data graveyards into commercial goldmines, enhancing RWE insights, regulatory approval speed, and revenue growth. Learn how data-first acquisition models outperform traditional M&A, and why AI-powered due diligence is key to unlocking billion-dollar opportunities.